Chronic equine proliferative pododermatitis
case report
DOI:
https://doi.org/10.11606/issn.1678-4456.bjvras.2019.160249Keywords:
Canker, Immune, Prednisolone, Purple mush, EquineAbstract
Chronic equine proliferative pododermatitis (canker) is a chronic hypertrophic disease of the hoof, denoted by an excessive proliferation of the horn-producing tissues, which results from a dyskeratosis of the keratinocytes. It occurs mainly at the frog and sulci regions, but can sometimes also affect the heels, sole, bulbs or hoof wall. The etiology still remains unclear. Infectious agents such as anaerobic bacteria, viruses, spirochetes and fungi have been isolated from diseased tissues, but, moreover, an immune cause has been suggested, possibly related to a genetic predisposition. This report shows a case of a Brazilian Sport Horse, 10 years old, that had been affected on the right hindlimb for more than two years without a concise diagnosis. Success was achieved with the treatment consisting of oral prednisolone and topical Purple Mush®.
Downloads
References
Apprich V, Licka T, Zipfl N, Tichy A, Gabriel C. Equine hoof canker: cell proliferation and morphology. Vet Pathol. 2017;54(4):661-8. http://dx.doi.org/10.1177/0300985817695515. PMid:28622496.
Apprich V, Licka T. Equine hoof canker: a clinical trial of topical cisplatin chemotherapy. Vet Rec. 2013;172(9):238. http://dx.doi.org/10.1136/vr.101359. PMid:23362179.
Baxter G. Manual of equine lameness. Ames: WileyBlackwell; 2011. Chapter 5, Common conditions of the foot; p. 244-245.
Brandt S, Schoster A, Tober R, Kainzbauer C, Burgstaller JP, Haralambus R, Steinborn R, Hinterhofer C, Stanek C. Consistent detection of bovine papillomavirus in lesions, intact skin and peripheral blood mononuclear cells of horses affected by hoof canker. Equine Vet J. 2011;43(2):202- 9. http://dx.doi.org/10.1111/j.2042-3306.2010.00147.x. PMid:21592216.
Jones K. Review of Sangre de Drago (Croton lechleri)-a South American Tree Sap in the treatment of diarrhea, inflammation, insect bites, viral infections, and wounds: traditional uses to clinical research. J Altern Complement Med. 2003;9(6):877- 96. http://dx.doi.org/10.1089/107555303771952235. PMid:14736360.
Jongbloets A, Sloet van Oldruitenborgh-Oosterbaan MM, Meeus PJ, Back W. Equine exudative canker: an (auto-) immune disease? Tijdschr Diergeneeskd. 2005;130(4):106- 9. PMid:15754903.
O’Grady S, Madison J. How to treat equine canker. Proceedings Am Assoc Equine Pract. 2004;50:202-5. O’Grady S. Canker. In: Baxter G. Adam’s and stashak lameness. 6th ed. Ames, Iowa: Wiley-Blackwell; 2011. p. 519-21.
Oosterlinck M, Deneut K, Dumoulin M, Gasthuys F, Pille F. Retrospective study on 30 horses with chronic proliferative pododermatitis (canker). Equine Vet Educ. 2011;23(9):466- 71. http://dx.doi.org/10.1111/j.2042-3292.2010.00213.x.
Oosterlinck M. Canker. In: Sprayberry K, Robinson NE. Robinson’s current therapy in equine medicine. 7th ed. St. Louis: Elsevier; 2015. p. 852-55. http://dx.doi.org/10.1016/ B978-1-4557-4555-5.00198-9.
Redding WR, O’Grady S. Nonseptic diseases associated with the hoof complex: keratoma, white line disease, canker and neoplasia. Vet Clin North Am Equine Pract. 2012;28(4):407-21.
Downloads
Published
Issue
Section
License
The journal content is authorized under the Creative Commons BY-NC-SA license (summary of the license: https://
